Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia

Autor: Maja Ludvigsen, Michael Roost Clausen, Bent Honoré, Stephen Hamilton-Dutoit, Trine Engelbrecht Hybel, Marie Beck Enemark, Martin Bjerregaard Pedersen, Trine Lindhardt Plesner, Henrik Frederiksen, Michael Boe Møller, Kristina Lystlund Lauridsen, Peter Nørgaard, Francesco d'Amore, Johanne Marie Holst

Publikováno v: Cancers
Holst, J M, Enemark, M B, Pedersen, M B, Lauridsen, K L, Hybel, T E, Clausen, M R, Frederiksen, H, Møller, M B, Nørgaard, P, Plesner, T L, Hamilton-Dutoit, S J, D’amore, F, Honoré, B & Ludvigsen, M 2021, ' Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia ', Cancers, vol. 13, no. 21, 5526 . https://doi.org/10.3390/cancers13215526
Volume 13
Issue 21
Cancers, Vol 13, Iss 5526, p 5526 (2021)

Simple Summary Patients are diagnosed with myeloproliferative neoplasia (MPN) and lymphoma more frequently in the population than expected, which has led to the hypothesis that the two malignancies may, in some cases, be pathogenetically related. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d08ace5f59f08bfa5a6936c4c22bdda
http://europepmc.org/articles/PMC8583469

Shared Genomic Alterations in Patients with Co-Existing Myeloproliferative Neoplasms and Angioimmunoblastic T-Cell Lymphoma

Autor: Chao Wang, Stephen Hamilton-Dutoit, Michael Boe Møller, Weiwei Zhang, Francesco d'Amore, Trine Lindhardt Plesner, Marcus Celik Hansen, Maja Ludvigsen, Wing C. Chan, Danilo Fiore, Giorgio Inghirami, Peter Noergaard, Bo Kok Mortensen, Martin Bjerregaard Pedersen, Wayne Tam, Henrik Frederiksen, Johanne Marie Holst

Publikováno v: Holst, J M, Pedersen, M B, Hansen, M C, Lindhardt Plesner, T, Frederiksen, H, Møller, M B, Hamilton-Dutoit, S J, Nørgaard, P, Mortensen, B K, Fiore, D, Wang, C, Wang, C, Tam, W, Ludvigsen, M, Chan, W C, Inghirami, G & d'Amore, F A 2019, ' Shared Genomic Alterations in Patients with Co-Existing Myeloproliferative Neoplasms and Angioimmunoblastic T-Cell Lymphoma ', Blood, vol. 134, no. Supplement 1, 2776 . https://doi.org/10.1182/blood-2019-131465
University of Southern Denmark
Holst, J M, Pedersen, M B, Hansen, M C, Lindhardt Plesner, T, Frederiksen, H, Møller, M, Hamilton-Dutoit, S J, Nørgaard, P, Mortensen, B K, Fiore, D, Wang, C, Wang, C, Tam, W, Ludvigsen, M, Chan, W C, Inghirami, G & d'Amore, F A 2019, ' Shared Genomic Alterations in Patients with Co-Existing Myeloproliferative Neoplasms and Angioimmunoblastic T-Cell Lymphoma ', American Society of Hematology: 61st Annual Meeting (ASH), Orlando, United States, 07/12/2019-10/12/2019 . < https://ash.confex.com/ash/2019/webprogram/Paper131465.html >

Background: Myeloproliferative neoplasia (MPN) and angioimmunoblastic T-cell lymphoma (AITL) are two distinct hematologic cancers. However, we have shown that patients with both malignancies probably occur with frequencies higher than expected in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b030c4e0750ddf7e034f1d70f9f834f
https://portal.findresearcher.sdu.dk/da/publications/3b5d4d69-5905-42b7-b2b5-0b29f1976d95

Changing the paradigms of treatment in peripheral T-cell lymphoma:from biology to clinical practice

Autor: Susan E. Bates, Govind Bhagat, Martin Bjerregaard Pedersen, Karthik A. Ganapathi, Dejan Radeski, Owen A. O'Connor, Francesco d'Amore

Publikováno v: O'Connor, O A, Bhagat, G, Ganapathi, K, Pedersen, M B, D'Amore, F, Radeski, D & Bates, S E 2014, ' Changing the paradigms of treatment in peripheral T-cell lymphoma : from biology to clinical practice ', Clinical Cancer Research, vol. 20, no. 20, e006363, pp. 5240-54 . https://doi.org/10.1158/1078-0432.CCR-14-2020

Despite enormous advances in our understanding of aggressive lymphomas, it is clear that progress in the peripheral T-cell lymphomas (PTCL) has lagged well behind other B-cell malignancies. Although there are many reasons for this, the one commonly c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9f66a732b583eb5011ea49127891f7
https://pure.au.dk/portal/da/publications/changing-the-paradigms-of-treatment-in-peripheral-tcell-lymphoma(e6ffd8b7-1eff-4a9a-8c63-7c36ca7b164a).html

Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Autor: Martin Bjerregaard Pedersen, Bent Honoré, Maja Ludvigsen, Tim Svenstrup Poulsen, Michael Boe Møller, Søren Besenbacher, Stephen Hamilton-Dutoit, Knud Bendix, Peter Nørgaard, Francesco d'Amore

Publikováno v: ResearcherID

Introduction: Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) is a heterogeneous group of mature T-cell lymphomas, probably composed by different biologically related subsets that have not yet been conclusively identified. In the WHO c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58ffb673f74c3f05703d4dd41d23e8f4
https://doi.org/10.1182/blood.v124.21.1623.1623

Clinical Outcome Determinants for Sequentially Transformed Indolent Lymphomas Treated with or without Autologous Stem Cell Transplantation

Autor: Maja Ølholm Vase, Bo Amdi Jensen, Paw Jensen, Martin Bjerregaard Pedersen, Charlotte Madsen, Michael Boe Moeller, Knud Bendix, Lars Munksgaard, Peter de Nully Brown, Preben Johansen, Francesco d'Amore, Erik Segel

Publikováno v: Madsen, C, Pedersen, M B, Vase, M Ø, Segel, E, Bendix, K, Jensen, B A, Jensen, P, Møller, M B, Johansen, P, Munksgaard, L, Brown, P D N & d'Amore, F 2014, ' Clinical Outcome Determinants for Sequentially Transformed Indolent Lymphomas Treated with or without Autologous Stem Cell Transplantation ', ASH Annual Meeting, San Francisco, United States, 06/12/2014-09/12/2014 . < http://www.bloodjournal.org/content/124/21/1194 >
Madsen, C, Pedersen, M B, Vase, M Ø, Segel, E, Bendix, K, Jensen, B A, Jensen, P, Møller, M B, Johansen, P, Munksgaard, L, Brown, P D N & D'Amore, F A 2014, ' Clinical outcome determinats for sequentially transformed indolent lymphomas treated with or without autologous stem cell transplantation ', Blood, vol. 124, no. 21 .
ResearcherID
Madsen, C, Pedersen, M B, Vase, M Ø, Segel, E, Bendix, K, Jensen, B A, Jensen, P, Møller, M B, Johansen, P, Munksgaard, L, Brown, P D N & d'Amore, F 2014, ' Clinical Outcome Determinants for Sequentially Transformed Indolent Lymphomas Treated with or without Autologous Stem Cell Transplantation ', Blood, vol. 124, no. 21 . < http://www.bloodjournal.org/content/124/21/1194 >
Aarhus University

Introduction: When lymphomas originally diagnosed as indolent (IL) transform to a more aggressive histology (TIL) the result is often an accelerated clinical course and a shortened survival. The purpose of this study was (i) to investigate whether au

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39021640323d769726d457ba409e115
https://doi.org/10.1182/blood.v124.21.1194.1194